Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL33551 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL1251343 | 1.00 | SLC34A1 (0.46) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL11896311 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL1291546 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL2996433 | 0.94 | SLC34A1 (0.42) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL9418491 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL1222462 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL183556 | 0.94 | SLC34A1 (0.42) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL2092139 | 0.94 | SLC34A1 (0.42) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL4947253 | 0.94 | SLC34A1 (0.42) | SLC34A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109809382-B | Method for synthesizing iron phosphate by using waste phosphate generated by precipitating trace heavy metals | 衢州华友钴新材料有限公司 | 2020-12-11 | — | — | CN | disclosed |
| US-20200360428-A1 | Methods of Reducing Doses of Erythropoietin Stimulating Agents in Hyporesponsive Patients | ROCKWELL MEDICAL INC (US) | 2020-11-19 | — | — | US | disclosed |
| CN-108039491-B | Sodium iron triphosphate as cathode material of sodium ion battery and preparation method thereof | 华南理工大学 | 2020-05-22 | — | — | CN | disclosed |
| EP-3065762-A1 | METHODS OF REDUCING DOSES OF ERYTHROPOIETIN STIMULATING AGENTS IN HYPORESPONSIVE PATIENTS | Rockwell Medical Inc. (US) | 2016-09-14 | — | — | EP | disclosed |
| US-20160250254-A1 | METHODS OF REDUCING DOSES OF ERYTHROPOIETIN STIMULATING AGENTS IN HYPORESPONSIVE PATIENTS | INNOVATUS LIFE SCIENCES LENDING FUND I, LP | 2016-09-01 | — | — | US | disclosed |
| WO-2015069656-A8 | METHODS OF REDUCING DOSES OF ERYTHROPOIETIN STIMULATING AGENTS IN HYPORESPONSIVE PATIENTS | ROCKWELL MEDICAL, INC. (US) | 2016-05-19 | — | — | WO | disclosed |
| WO-2015069656-A1 | METHODS OF REDUCING DOSES OF ERYTHROPOIETIN STIMULATING AGENTS IN HYPORESPONSIVE PATIENTS | ROCKWELL MEDICAL, INC. (US) | 2015-05-14 | — | — | WO | disclosed |